ARROWHEAD PHARMACEUTICALS, INC. Impairment of Intangible Assets (Excluding Goodwill)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Impairment of Intangible Assets (Excluding Goodwill) of $944.93 thousand for the 12-month period ending 2016-09-30, per its 10-K filed 2016-12-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2016-12-14
- ARROWHEAD PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2016 was $944.93K.
- ARROWHEAD PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2014 was $2.17M, a 66.08% increase from fiscal 2013.
- ARROWHEAD PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2013 was $1.31M.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|
| 2016-09-30 | $944.93K 10-K · filed 2016-12-14 |
| 2014-09-30 | $2.17M 10-K · filed 2015-12-14 |
| 2013-09-30 | $1.31M 10-K · filed 2015-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |